English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The rise of ‘superbugs’ like methicillin-resistant Staphylococcus aureus threatens human health on a global scale. Bacteria have established many ways to withstand antimicrobial treatments, evade the immune system and protect them from external stressors. Current medical care frequently fails to eradicate multi-drug resistant bacteria, microbial biofilms and small colony variants that can hide from antibiotic treatments inside human cells, therefore, drug discovery and drug development to improve healthcare is pivotal. In this article, novel antimicrobial strategies with extensive activity against multi-drug resistant staphylococci are described, including:

Tackling superbugs in their slime castles: innovative approaches against antimicrobial-resistant biofilm infections